Boston Scientific shares dropped about 3.9% in pre-market trading after the company revised its full-year outlook.
The medical device maker updated its forecast, which shifted investor sentiment and triggered the decline. According to Jin10, the change reflects evolving market conditions and internal strategy adjustments.
The revision has led investors to reassess expectations as the company navigates a more challenging operating environment for growth projection
#binance #muhammadajmal_0 #TrendingTopic
USDC
0.99988
+0.02%
BTC
76,923.81
-1.08%